INFOGRAPHICS
01.
BRIEF: Create an infographic for the content provided below.
What are mobile apps?
Mobile apps are software programs you can download and access directly using your phone or another
mobile device – like a tablet or music player.
Interesting facts about mobile apps
1- Freemium apps generate 98% of all mobile app revenue
2- 60% of new mobile apps are never updated after release
3- 79% of messaging app users engage with brands via the apps
4- 84% of consumers plan to shop for gifts at physical stores during the 2015 holiday season, compared to 78% for online via PC, 20% for retailer app, and 16% for mobile internet via smartphones.
How to create a successful mobile app
Phase 1 – Strategy – This initial phase
is to determine and refine what success for your app looks like to your organization and to create a roadmap of the process that you will take to achieve those goals.
Phase 2 – Design – In this phase, the most important point is to focus on the user experience – i.e., the interface, functions and application performance that your users will have in the palms of their hands.
Phase 3 – Development – In this phase developers should develop the app in a way that allows performance to be monitored throughout the app’s deployment and use.
Phase 4 – Marketing – Make sure that potential users know the app exists, like it and
share it with friends. Phase 5 – Maintenance & Management
Keep your customers engaged and coming back by delivering a seamless experience that
makes your app stick.
share it with friends. Phase 5 – Maintenance & Management
Keep your customers engaged and coming back by delivering a seamless experience that
makes your app stick.
02.
BRIEF: Create an infographic using the data given below.
Sample data:
More than 29 million US adults have diabetes, and 25% of them don’t know it.
About 86 million US adults— more than a third—have prediabetes, and
90% of them don’t know it.
90% of them don’t know it.
People with prediabetes who take part in a structured lifestyle change program can cut their risk of developing type 2 diabetes by as much as 58%.
BRIEF: Recreate this image and add your creative judgment to improve the quality.
BRIEF: Make this text-heavy slide into a visually appealing slide.
Slide title: Oral semaglutide safety information
CONTRAINDICATIONS:
Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2.
Prior serious hypersensitivity reaction to semaglutide or any of the excipients in RYBELSUS.
WARNINGS AND PRECAUTIONS:
Pancreatitis: Has been reported in clinical trials. Discontinue promptly if pancreatitis is suspected. Do not restart if pancreatitis is confirmed.
Diabetic Retinopathy Complications: Has been reported in a cardiovascular outcomes trial with semaglutide injection. Patients with a history of diabetic retinopathy should be monitored.
Hypoglycemia: Concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia, including severe hypoglycemia. Reducing dose of insulin secretagogue or insulin may be necessary.
Acute Kidney Injury: Monitor renal function in patients with renal impairment reporting severe adverse gastrointestinal reactions.
Hypersensitivity Reactions: Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue RYBELSUS if suspected and promptly seek medical advice.
ADVERSE REACTIONS:
The most common adverse reactions, reported in ≥5% of patients treated with RYBELSUS are: nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation.
THANK YOU!
